nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—Alfuzosin—CYP3A4—bone cancer	0.0218	1	CrCbGaD
Terazosin—Cardiac failure—Epirubicin—bone cancer	0.00436	0.00446	CcSEcCtD
Terazosin—Cerebrovascular accident—Epirubicin—bone cancer	0.00435	0.00444	CcSEcCtD
Terazosin—Convulsion—Cisplatin—bone cancer	0.00433	0.00442	CcSEcCtD
Terazosin—Pain in extremity—Epirubicin—bone cancer	0.00426	0.00435	CcSEcCtD
Terazosin—Osteoarthritis—Epirubicin—bone cancer	0.00426	0.00435	CcSEcCtD
Terazosin—Myalgia—Cisplatin—bone cancer	0.00425	0.00435	CcSEcCtD
Terazosin—Anxiety—Cisplatin—bone cancer	0.00424	0.00433	CcSEcCtD
Terazosin—Discomfort—Cisplatin—bone cancer	0.0042	0.00429	CcSEcCtD
Terazosin—Migraine—Epirubicin—bone cancer	0.00419	0.00428	CcSEcCtD
Terazosin—Face oedema—Epirubicin—bone cancer	0.00411	0.0042	CcSEcCtD
Terazosin—Oedema—Cisplatin—bone cancer	0.00408	0.00417	CcSEcCtD
Terazosin—Anaphylactic shock—Cisplatin—bone cancer	0.00408	0.00417	CcSEcCtD
Terazosin—Anaphylactoid reaction—Doxorubicin—bone cancer	0.00407	0.00416	CcSEcCtD
Terazosin—Cardiac failure—Doxorubicin—bone cancer	0.00404	0.00413	CcSEcCtD
Terazosin—Cerebrovascular accident—Doxorubicin—bone cancer	0.00402	0.00411	CcSEcCtD
Terazosin—Thrombocytopenia—Cisplatin—bone cancer	0.00399	0.00408	CcSEcCtD
Terazosin—Tachycardia—Cisplatin—bone cancer	0.00398	0.00407	CcSEcCtD
Terazosin—Osteoarthritis—Doxorubicin—bone cancer	0.00394	0.00403	CcSEcCtD
Terazosin—Pain in extremity—Doxorubicin—bone cancer	0.00394	0.00403	CcSEcCtD
Terazosin—Hyperhidrosis—Cisplatin—bone cancer	0.00394	0.00403	CcSEcCtD
Terazosin—Asthma—Methotrexate—bone cancer	0.00393	0.00402	CcSEcCtD
Terazosin—Orthostatic hypotension—Epirubicin—bone cancer	0.00389	0.00398	CcSEcCtD
Terazosin—Anorexia—Cisplatin—bone cancer	0.00388	0.00397	CcSEcCtD
Terazosin—Migraine—Doxorubicin—bone cancer	0.00388	0.00396	CcSEcCtD
Terazosin—Hypokalaemia—Epirubicin—bone cancer	0.00388	0.00396	CcSEcCtD
Terazosin—Hypotension—Cisplatin—bone cancer	0.00381	0.00389	CcSEcCtD
Terazosin—Nasopharyngitis—Epirubicin—bone cancer	0.00381	0.00389	CcSEcCtD
Terazosin—Face oedema—Doxorubicin—bone cancer	0.0038	0.00389	CcSEcCtD
Terazosin—Gastritis—Epirubicin—bone cancer	0.00377	0.00385	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00371	0.0038	CcSEcCtD
Terazosin—Influenza—Epirubicin—bone cancer	0.00368	0.00376	CcSEcCtD
Terazosin—Asthma—Epirubicin—bone cancer	0.00368	0.00376	CcSEcCtD
Terazosin—Dysuria—Methotrexate—bone cancer	0.00368	0.00376	CcSEcCtD
Terazosin—Paraesthesia—Cisplatin—bone cancer	0.00366	0.00374	CcSEcCtD
Terazosin—Dyspnoea—Cisplatin—bone cancer	0.00363	0.00371	CcSEcCtD
Terazosin—Erectile dysfunction—Methotrexate—bone cancer	0.00362	0.0037	CcSEcCtD
Terazosin—Orthostatic hypotension—Doxorubicin—bone cancer	0.0036	0.00368	CcSEcCtD
Terazosin—Photosensitivity reaction—Methotrexate—bone cancer	0.00359	0.00367	CcSEcCtD
Terazosin—Hypokalaemia—Doxorubicin—bone cancer	0.00359	0.00367	CcSEcCtD
Terazosin—Angina pectoris—Epirubicin—bone cancer	0.00358	0.00366	CcSEcCtD
Terazosin—Decreased appetite—Cisplatin—bone cancer	0.00354	0.00362	CcSEcCtD
Terazosin—Bronchitis—Epirubicin—bone cancer	0.00354	0.00362	CcSEcCtD
Terazosin—Nasopharyngitis—Doxorubicin—bone cancer	0.00352	0.0036	CcSEcCtD
Terazosin—Depression—Methotrexate—bone cancer	0.0035	0.00357	CcSEcCtD
Terazosin—Gastritis—Doxorubicin—bone cancer	0.00349	0.00356	CcSEcCtD
Terazosin—Pain—Cisplatin—bone cancer	0.00348	0.00356	CcSEcCtD
Terazosin—Dysuria—Epirubicin—bone cancer	0.00344	0.00352	CcSEcCtD
Terazosin—Conjunctivitis—Methotrexate—bone cancer	0.00341	0.00348	CcSEcCtD
Terazosin—Asthma—Doxorubicin—bone cancer	0.00341	0.00348	CcSEcCtD
Terazosin—Influenza—Doxorubicin—bone cancer	0.00341	0.00348	CcSEcCtD
Terazosin—Pollakiuria—Epirubicin—bone cancer	0.0034	0.00348	CcSEcCtD
Terazosin—Sweating—Methotrexate—bone cancer	0.00336	0.00344	CcSEcCtD
Terazosin—Photosensitivity reaction—Epirubicin—bone cancer	0.00336	0.00343	CcSEcCtD
Terazosin—Feeling abnormal—Cisplatin—bone cancer	0.00336	0.00343	CcSEcCtD
Terazosin—Weight increased—Epirubicin—bone cancer	0.00335	0.00342	CcSEcCtD
Terazosin—Angina pectoris—Doxorubicin—bone cancer	0.00332	0.00339	CcSEcCtD
Terazosin—Epistaxis—Methotrexate—bone cancer	0.00331	0.00338	CcSEcCtD
Terazosin—Bronchitis—Doxorubicin—bone cancer	0.00327	0.00335	CcSEcCtD
Terazosin—Body temperature increased—Cisplatin—bone cancer	0.00322	0.00329	CcSEcCtD
Terazosin—Jaundice—Epirubicin—bone cancer	0.0032	0.00327	CcSEcCtD
Terazosin—Urinary tract infection—Epirubicin—bone cancer	0.00319	0.00326	CcSEcCtD
Terazosin—Conjunctivitis—Epirubicin—bone cancer	0.00319	0.00326	CcSEcCtD
Terazosin—Dysuria—Doxorubicin—bone cancer	0.00318	0.00326	CcSEcCtD
Terazosin—Sweating—Epirubicin—bone cancer	0.00315	0.00322	CcSEcCtD
Terazosin—Pollakiuria—Doxorubicin—bone cancer	0.00315	0.00322	CcSEcCtD
Terazosin—Pharyngitis—Methotrexate—bone cancer	0.00312	0.00319	CcSEcCtD
Terazosin—Photosensitivity reaction—Doxorubicin—bone cancer	0.00311	0.00318	CcSEcCtD
Terazosin—Weight increased—Doxorubicin—bone cancer	0.0031	0.00317	CcSEcCtD
Terazosin—Epistaxis—Epirubicin—bone cancer	0.0031	0.00316	CcSEcCtD
Terazosin—Sinusitis—Epirubicin—bone cancer	0.00308	0.00315	CcSEcCtD
Terazosin—Visual impairment—Methotrexate—bone cancer	0.00303	0.0031	CcSEcCtD
Terazosin—Hypersensitivity—Cisplatin—bone cancer	0.003	0.00307	CcSEcCtD
Terazosin—Jaundice—Doxorubicin—bone cancer	0.00296	0.00303	CcSEcCtD
Terazosin—Rhinitis—Epirubicin—bone cancer	0.00295	0.00302	CcSEcCtD
Terazosin—Urinary tract infection—Doxorubicin—bone cancer	0.00295	0.00302	CcSEcCtD
Terazosin—Conjunctivitis—Doxorubicin—bone cancer	0.00295	0.00302	CcSEcCtD
Terazosin—Eye disorder—Methotrexate—bone cancer	0.00294	0.00301	CcSEcCtD
Terazosin—Tinnitus—Methotrexate—bone cancer	0.00293	0.003	CcSEcCtD
Terazosin—Asthenia—Cisplatin—bone cancer	0.00292	0.00299	CcSEcCtD
Terazosin—Pharyngitis—Epirubicin—bone cancer	0.00292	0.00299	CcSEcCtD
Terazosin—Sweating—Doxorubicin—bone cancer	0.00291	0.00298	CcSEcCtD
Terazosin—Oedema peripheral—Epirubicin—bone cancer	0.0029	0.00297	CcSEcCtD
Terazosin—Epistaxis—Doxorubicin—bone cancer	0.00286	0.00293	CcSEcCtD
Terazosin—Sinusitis—Doxorubicin—bone cancer	0.00285	0.00291	CcSEcCtD
Terazosin—Visual impairment—Epirubicin—bone cancer	0.00284	0.0029	CcSEcCtD
Terazosin—Diarrhoea—Cisplatin—bone cancer	0.00279	0.00285	CcSEcCtD
Terazosin—Eye disorder—Epirubicin—bone cancer	0.00275	0.00281	CcSEcCtD
Terazosin—Tinnitus—Epirubicin—bone cancer	0.00275	0.00281	CcSEcCtD
Terazosin—Malnutrition—Methotrexate—bone cancer	0.00274	0.0028	CcSEcCtD
Terazosin—Rhinitis—Doxorubicin—bone cancer	0.00273	0.00279	CcSEcCtD
Terazosin—Pharyngitis—Doxorubicin—bone cancer	0.00271	0.00277	CcSEcCtD
Terazosin—Oedema peripheral—Doxorubicin—bone cancer	0.00269	0.00274	CcSEcCtD
Terazosin—Dysgeusia—Methotrexate—bone cancer	0.00268	0.00274	CcSEcCtD
Terazosin—Back pain—Methotrexate—bone cancer	0.00265	0.00271	CcSEcCtD
Terazosin—Arrhythmia—Epirubicin—bone cancer	0.00263	0.00269	CcSEcCtD
Terazosin—Visual impairment—Doxorubicin—bone cancer	0.00263	0.00269	CcSEcCtD
Terazosin—Vomiting—Cisplatin—bone cancer	0.00259	0.00265	CcSEcCtD
Terazosin—Vision blurred—Methotrexate—bone cancer	0.00258	0.00264	CcSEcCtD
Terazosin—Rash—Cisplatin—bone cancer	0.00257	0.00263	CcSEcCtD
Terazosin—Dermatitis—Cisplatin—bone cancer	0.00257	0.00262	CcSEcCtD
Terazosin—Malnutrition—Epirubicin—bone cancer	0.00256	0.00262	CcSEcCtD
Terazosin—Eye disorder—Doxorubicin—bone cancer	0.00255	0.0026	CcSEcCtD
Terazosin—Ill-defined disorder—Methotrexate—bone cancer	0.00254	0.0026	CcSEcCtD
Terazosin—Tinnitus—Doxorubicin—bone cancer	0.00254	0.0026	CcSEcCtD
Terazosin—Flatulence—Epirubicin—bone cancer	0.00253	0.00258	CcSEcCtD
Terazosin—Tension—Epirubicin—bone cancer	0.00252	0.00257	CcSEcCtD
Terazosin—Dysgeusia—Epirubicin—bone cancer	0.00251	0.00257	CcSEcCtD
Terazosin—Nervousness—Epirubicin—bone cancer	0.00249	0.00255	CcSEcCtD
Terazosin—Back pain—Epirubicin—bone cancer	0.00248	0.00254	CcSEcCtD
Terazosin—Malaise—Methotrexate—bone cancer	0.00247	0.00253	CcSEcCtD
Terazosin—Vertigo—Methotrexate—bone cancer	0.00246	0.00252	CcSEcCtD
Terazosin—Arrhythmia—Doxorubicin—bone cancer	0.00243	0.00249	CcSEcCtD
Terazosin—Nausea—Cisplatin—bone cancer	0.00242	0.00247	CcSEcCtD
Terazosin—Vision blurred—Epirubicin—bone cancer	0.00242	0.00247	CcSEcCtD
Terazosin—Cough—Methotrexate—bone cancer	0.00239	0.00244	CcSEcCtD
Terazosin—Ill-defined disorder—Epirubicin—bone cancer	0.00238	0.00243	CcSEcCtD
Terazosin—Convulsion—Methotrexate—bone cancer	0.00237	0.00243	CcSEcCtD
Terazosin—Malnutrition—Doxorubicin—bone cancer	0.00237	0.00243	CcSEcCtD
Terazosin—Flatulence—Doxorubicin—bone cancer	0.00234	0.00239	CcSEcCtD
Terazosin—Chest pain—Methotrexate—bone cancer	0.00233	0.00238	CcSEcCtD
Terazosin—Myalgia—Methotrexate—bone cancer	0.00233	0.00238	CcSEcCtD
Terazosin—Arthralgia—Methotrexate—bone cancer	0.00233	0.00238	CcSEcCtD
Terazosin—Tension—Doxorubicin—bone cancer	0.00233	0.00238	CcSEcCtD
Terazosin—Dysgeusia—Doxorubicin—bone cancer	0.00232	0.00238	CcSEcCtD
Terazosin—Malaise—Epirubicin—bone cancer	0.00231	0.00236	CcSEcCtD
Terazosin—Discomfort—Methotrexate—bone cancer	0.0023	0.00236	CcSEcCtD
Terazosin—Nervousness—Doxorubicin—bone cancer	0.0023	0.00236	CcSEcCtD
Terazosin—Vertigo—Epirubicin—bone cancer	0.0023	0.00236	CcSEcCtD
Terazosin—Syncope—Epirubicin—bone cancer	0.0023	0.00235	CcSEcCtD
Terazosin—Back pain—Doxorubicin—bone cancer	0.0023	0.00235	CcSEcCtD
Terazosin—Palpitations—Epirubicin—bone cancer	0.00227	0.00232	CcSEcCtD
Terazosin—Confusional state—Methotrexate—bone cancer	0.00225	0.00231	CcSEcCtD
Terazosin—Loss of consciousness—Epirubicin—bone cancer	0.00225	0.0023	CcSEcCtD
Terazosin—Cough—Epirubicin—bone cancer	0.00224	0.00229	CcSEcCtD
Terazosin—Anaphylactic shock—Methotrexate—bone cancer	0.00224	0.00229	CcSEcCtD
Terazosin—Vision blurred—Doxorubicin—bone cancer	0.00224	0.00229	CcSEcCtD
Terazosin—Convulsion—Epirubicin—bone cancer	0.00222	0.00227	CcSEcCtD
Terazosin—Ill-defined disorder—Doxorubicin—bone cancer	0.0022	0.00225	CcSEcCtD
Terazosin—Thrombocytopenia—Methotrexate—bone cancer	0.00219	0.00224	CcSEcCtD
Terazosin—Arthralgia—Epirubicin—bone cancer	0.00218	0.00223	CcSEcCtD
Terazosin—Myalgia—Epirubicin—bone cancer	0.00218	0.00223	CcSEcCtD
Terazosin—Chest pain—Epirubicin—bone cancer	0.00218	0.00223	CcSEcCtD
Terazosin—Anxiety—Epirubicin—bone cancer	0.00218	0.00222	CcSEcCtD
Terazosin—Hyperhidrosis—Methotrexate—bone cancer	0.00216	0.00221	CcSEcCtD
Terazosin—Discomfort—Epirubicin—bone cancer	0.00216	0.0022	CcSEcCtD
Terazosin—Malaise—Doxorubicin—bone cancer	0.00214	0.00219	CcSEcCtD
Terazosin—Dry mouth—Epirubicin—bone cancer	0.00214	0.00218	CcSEcCtD
Terazosin—Vertigo—Doxorubicin—bone cancer	0.00213	0.00218	CcSEcCtD
Terazosin—Anorexia—Methotrexate—bone cancer	0.00213	0.00218	CcSEcCtD
Terazosin—Syncope—Doxorubicin—bone cancer	0.00213	0.00218	CcSEcCtD
Terazosin—Confusional state—Epirubicin—bone cancer	0.00211	0.00216	CcSEcCtD
Terazosin—Palpitations—Doxorubicin—bone cancer	0.0021	0.00214	CcSEcCtD
Terazosin—Oedema—Epirubicin—bone cancer	0.00209	0.00214	CcSEcCtD
Terazosin—Anaphylactic shock—Epirubicin—bone cancer	0.00209	0.00214	CcSEcCtD
Terazosin—Hypotension—Methotrexate—bone cancer	0.00209	0.00214	CcSEcCtD
Terazosin—Loss of consciousness—Doxorubicin—bone cancer	0.00209	0.00213	CcSEcCtD
Terazosin—Cough—Doxorubicin—bone cancer	0.00207	0.00212	CcSEcCtD
Terazosin—Shock—Epirubicin—bone cancer	0.00206	0.0021	CcSEcCtD
Terazosin—Convulsion—Doxorubicin—bone cancer	0.00206	0.0021	CcSEcCtD
Terazosin—Thrombocytopenia—Epirubicin—bone cancer	0.00205	0.00209	CcSEcCtD
Terazosin—Tachycardia—Epirubicin—bone cancer	0.00204	0.00209	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00204	0.00208	CcSEcCtD
Terazosin—Hyperhidrosis—Epirubicin—bone cancer	0.00202	0.00207	CcSEcCtD
Terazosin—Insomnia—Methotrexate—bone cancer	0.00202	0.00207	CcSEcCtD
Terazosin—Chest pain—Doxorubicin—bone cancer	0.00202	0.00206	CcSEcCtD
Terazosin—Myalgia—Doxorubicin—bone cancer	0.00202	0.00206	CcSEcCtD
Terazosin—Arthralgia—Doxorubicin—bone cancer	0.00202	0.00206	CcSEcCtD
Terazosin—Anxiety—Doxorubicin—bone cancer	0.00201	0.00206	CcSEcCtD
Terazosin—Paraesthesia—Methotrexate—bone cancer	0.00201	0.00205	CcSEcCtD
Terazosin—Discomfort—Doxorubicin—bone cancer	0.002	0.00204	CcSEcCtD
Terazosin—Anorexia—Epirubicin—bone cancer	0.00199	0.00204	CcSEcCtD
Terazosin—Dyspnoea—Methotrexate—bone cancer	0.00199	0.00204	CcSEcCtD
Terazosin—Somnolence—Methotrexate—bone cancer	0.00199	0.00203	CcSEcCtD
Terazosin—Dry mouth—Doxorubicin—bone cancer	0.00198	0.00202	CcSEcCtD
Terazosin—Dyspepsia—Methotrexate—bone cancer	0.00197	0.00201	CcSEcCtD
Terazosin—Hypotension—Epirubicin—bone cancer	0.00196	0.002	CcSEcCtD
Terazosin—Confusional state—Doxorubicin—bone cancer	0.00195	0.002	CcSEcCtD
Terazosin—Decreased appetite—Methotrexate—bone cancer	0.00194	0.00199	CcSEcCtD
Terazosin—Anaphylactic shock—Doxorubicin—bone cancer	0.00194	0.00198	CcSEcCtD
Terazosin—Oedema—Doxorubicin—bone cancer	0.00194	0.00198	CcSEcCtD
Terazosin—Fatigue—Methotrexate—bone cancer	0.00193	0.00197	CcSEcCtD
Terazosin—Pain—Methotrexate—bone cancer	0.00191	0.00195	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00191	0.00195	CcSEcCtD
Terazosin—Shock—Doxorubicin—bone cancer	0.00191	0.00195	CcSEcCtD
Terazosin—Thrombocytopenia—Doxorubicin—bone cancer	0.0019	0.00194	CcSEcCtD
Terazosin—Insomnia—Epirubicin—bone cancer	0.00189	0.00193	CcSEcCtD
Terazosin—Tachycardia—Doxorubicin—bone cancer	0.00189	0.00193	CcSEcCtD
Terazosin—Paraesthesia—Epirubicin—bone cancer	0.00188	0.00192	CcSEcCtD
Terazosin—Hyperhidrosis—Doxorubicin—bone cancer	0.00187	0.00191	CcSEcCtD
Terazosin—Dyspnoea—Epirubicin—bone cancer	0.00187	0.00191	CcSEcCtD
Terazosin—Somnolence—Epirubicin—bone cancer	0.00186	0.0019	CcSEcCtD
Terazosin—Anorexia—Doxorubicin—bone cancer	0.00185	0.00189	CcSEcCtD
Terazosin—Feeling abnormal—Methotrexate—bone cancer	0.00184	0.00188	CcSEcCtD
Terazosin—Dyspepsia—Epirubicin—bone cancer	0.00184	0.00188	CcSEcCtD
Terazosin—Gastrointestinal pain—Methotrexate—bone cancer	0.00183	0.00187	CcSEcCtD
Terazosin—Decreased appetite—Epirubicin—bone cancer	0.00182	0.00186	CcSEcCtD
Terazosin—Hypotension—Doxorubicin—bone cancer	0.00181	0.00185	CcSEcCtD
Terazosin—Fatigue—Epirubicin—bone cancer	0.0018	0.00184	CcSEcCtD
Terazosin—Pain—Epirubicin—bone cancer	0.00179	0.00183	CcSEcCtD
Terazosin—Constipation—Epirubicin—bone cancer	0.00179	0.00183	CcSEcCtD
Terazosin—Body temperature increased—Methotrexate—bone cancer	0.00177	0.00181	CcSEcCtD
Terazosin—Abdominal pain—Methotrexate—bone cancer	0.00177	0.00181	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00176	0.0018	CcSEcCtD
Terazosin—Insomnia—Doxorubicin—bone cancer	0.00175	0.00179	CcSEcCtD
Terazosin—Paraesthesia—Doxorubicin—bone cancer	0.00174	0.00178	CcSEcCtD
Terazosin—Dyspnoea—Doxorubicin—bone cancer	0.00173	0.00176	CcSEcCtD
Terazosin—Feeling abnormal—Epirubicin—bone cancer	0.00172	0.00176	CcSEcCtD
Terazosin—Somnolence—Doxorubicin—bone cancer	0.00172	0.00176	CcSEcCtD
Terazosin—Gastrointestinal pain—Epirubicin—bone cancer	0.00171	0.00175	CcSEcCtD
Terazosin—Dyspepsia—Doxorubicin—bone cancer	0.0017	0.00174	CcSEcCtD
Terazosin—Decreased appetite—Doxorubicin—bone cancer	0.00168	0.00172	CcSEcCtD
Terazosin—Fatigue—Doxorubicin—bone cancer	0.00167	0.00171	CcSEcCtD
Terazosin—Constipation—Doxorubicin—bone cancer	0.00166	0.00169	CcSEcCtD
Terazosin—Pain—Doxorubicin—bone cancer	0.00166	0.00169	CcSEcCtD
Terazosin—Body temperature increased—Epirubicin—bone cancer	0.00165	0.00169	CcSEcCtD
Terazosin—Abdominal pain—Epirubicin—bone cancer	0.00165	0.00169	CcSEcCtD
Terazosin—Hypersensitivity—Methotrexate—bone cancer	0.00165	0.00168	CcSEcCtD
Terazosin—Asthenia—Methotrexate—bone cancer	0.0016	0.00164	CcSEcCtD
Terazosin—Feeling abnormal—Doxorubicin—bone cancer	0.0016	0.00163	CcSEcCtD
Terazosin—Gastrointestinal pain—Doxorubicin—bone cancer	0.00158	0.00162	CcSEcCtD
Terazosin—Pruritus—Methotrexate—bone cancer	0.00158	0.00162	CcSEcCtD
Terazosin—Hypersensitivity—Epirubicin—bone cancer	0.00154	0.00158	CcSEcCtD
Terazosin—Abdominal pain—Doxorubicin—bone cancer	0.00153	0.00156	CcSEcCtD
Terazosin—Body temperature increased—Doxorubicin—bone cancer	0.00153	0.00156	CcSEcCtD
Terazosin—Diarrhoea—Methotrexate—bone cancer	0.00153	0.00156	CcSEcCtD
Terazosin—Asthenia—Epirubicin—bone cancer	0.0015	0.00153	CcSEcCtD
Terazosin—Pruritus—Epirubicin—bone cancer	0.00148	0.00151	CcSEcCtD
Terazosin—Dizziness—Methotrexate—bone cancer	0.00148	0.00151	CcSEcCtD
Terazosin—Diarrhoea—Epirubicin—bone cancer	0.00143	0.00146	CcSEcCtD
Terazosin—Hypersensitivity—Doxorubicin—bone cancer	0.00143	0.00146	CcSEcCtD
Terazosin—Vomiting—Methotrexate—bone cancer	0.00142	0.00145	CcSEcCtD
Terazosin—Rash—Methotrexate—bone cancer	0.00141	0.00144	CcSEcCtD
Terazosin—Dermatitis—Methotrexate—bone cancer	0.00141	0.00144	CcSEcCtD
Terazosin—Headache—Methotrexate—bone cancer	0.0014	0.00143	CcSEcCtD
Terazosin—Asthenia—Doxorubicin—bone cancer	0.00139	0.00142	CcSEcCtD
Terazosin—Dizziness—Epirubicin—bone cancer	0.00138	0.00141	CcSEcCtD
Terazosin—Pruritus—Doxorubicin—bone cancer	0.00137	0.0014	CcSEcCtD
Terazosin—Vomiting—Epirubicin—bone cancer	0.00133	0.00136	CcSEcCtD
Terazosin—Nausea—Methotrexate—bone cancer	0.00133	0.00136	CcSEcCtD
Terazosin—Diarrhoea—Doxorubicin—bone cancer	0.00132	0.00135	CcSEcCtD
Terazosin—Rash—Epirubicin—bone cancer	0.00132	0.00135	CcSEcCtD
Terazosin—Dermatitis—Epirubicin—bone cancer	0.00132	0.00135	CcSEcCtD
Terazosin—Headache—Epirubicin—bone cancer	0.00131	0.00134	CcSEcCtD
Terazosin—Dizziness—Doxorubicin—bone cancer	0.00128	0.00131	CcSEcCtD
Terazosin—Nausea—Epirubicin—bone cancer	0.00124	0.00127	CcSEcCtD
Terazosin—Vomiting—Doxorubicin—bone cancer	0.00123	0.00126	CcSEcCtD
Terazosin—Rash—Doxorubicin—bone cancer	0.00122	0.00125	CcSEcCtD
Terazosin—Dermatitis—Doxorubicin—bone cancer	0.00122	0.00125	CcSEcCtD
Terazosin—Headache—Doxorubicin—bone cancer	0.00121	0.00124	CcSEcCtD
Terazosin—Nausea—Doxorubicin—bone cancer	0.00115	0.00118	CcSEcCtD
